期刊文献+

不同民族食管癌患者血清CYFRA21-1水平分析 被引量:1

Study on the Serum CYFRA21-1 Levels in Chinese Patients of DifferentNationalities with Esophageal Cancer
下载PDF
导出
摘要 目的:探讨血清细胞角蛋白19片段(CYFRA21-1)在不同民族食管癌患者中的差异。方法:采用 放射免疫分析检测79例健康人,264例食管癌患者血清CYFRA21-1的水平并对其结果进行分析,将食管癌 组按民族分为4组,130例汉族,72例维族,32例哈族,及其他为12例蒙古族、11例回族和7例柯尔克孜族。 结果:1.CYFRA21-1浓度在其平均秩和正常对照为169.05ng/ml,食管癌患者总样本为298.54ng/ml,汉族 312.89ng/ml,维族为288.27ng/ml,哈族为211.73ng/ml,其他440.11ng/ml,两两比较发现食管癌总体、汉族、维 族及其他正常对照均有统计学意义(P<0.01),汉族与哈族(P<0.05)、维族与哈族(P<0.01)、哈族与其他(P <0.01)、哈族与食管癌总样本组(P<0.05)其他与总样本组(P<0.01)血清CYFRA21-1水平有统计学意义。 2.CYFRA21-1水平当界值为3.3ng/ml时,阳性率在正常对照组为0%,食管癌患者总样本组29.41%,汉族 32.31%,维族为25.00%,哈族为15.63%,其他为26.67%。率的比较发现,维族与其他(P<0.05)、哈族与其 他(P<0.05)、各民族与正常对照均有统计学意义(P<0.01)。结论:血清细胞角蛋白19片段(CYFRA21-1) 水平在不同民族食管癌患者中有差异。 Objective To investigate the serum levels of cytokeratin 19 fragment (CYFRA21-1) in chinese people of different nationalities with esophageal cancer. Methods Serum CYFRA21-1 levels were measured with RIA in 79 controls and 264 chinese patients of different nationalities with esophageal cancer. The nationalities of the patients consisted of: Han 130, uighur 72, kazakh 32 and others 30 (including mongol 12, hui 11, keerkezi 7). Results (1) The serum levels of CYFRA21-1 obtained in different groups were: controls 169.05ng/ml, patients as a whole 299.84ng/ml, Han patients 312.89ng/ml, uighurs 288.27ng/ml, kazakhs 211.73ng/ml, others 440.11ng/ml. Levels in the patients as a whole and of various nationalitis (except kazakhs) were significantly higher than those in the controls (P<0.01). Differences of levels between kazakhs and hans、 others、patients as a whole were all significantl (P<0.05, P<0.01, P<0.05). (2) When 3.3ng/ml was taken as the cut-off value, the positive rate was 0% in the controls, 29,14% in patients as a whole, 32.3% in Hans, 25.00% in uighurs, 15.63% in kazakhs and 26.67% in others. Differences between uighurs and others、kazakhs and others、patients of various nationalities and controls were all significant (P<0.01). Conclusion There were differences among the serum CYFRA21-1 levels in chinese patients of different nationalities with esophageal cancer.
出处 《放射免疫学杂志》 CAS 2005年第1期31-33,共3页 Journal of Radioimmanology
关键词 食管癌 CYFRA21-1 哈族 患者 血清 维族 不同民族 汉族 水平 发现 CYFRA21-1, esophageal cancer, nation, serum
  • 相关文献

参考文献2

二级参考文献11

  • 1Pujol JL,Grenier J,Daures JP,et al.Serum fragment of cytokeratin subunit 19 measured by CYFRA21-1 immunoradiometric assay as a marker of lung cancer [J].Cancer Res,1993,53:61-66.
  • 2Doweck I,Barak M.Cyfra21-1.A new potential tumor maker for squamous cell carcinoma of head and neck [J].Arch Otolaryngol Head Neck Surg,1995,121:177-181.
  • 3Traweek ST,Liu J,Battifora H.Keratin gene expression in non-epithelial tissues.Detection with polymerase chain reaction [J].Am J Pathol,1993,142:1111-1118.
  • 4Broers JL,Ramaekers FC,Rot MK,et al.Cytokeratins in different types of human lung cancers as monitored by chain-specific monoclonal antibodies [J].Cancer Res,1988,48:3221-3229.
  • 5Burchills SA,Bradbury MF,Pittman K,et al.Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction [J].Br J Cancer,1995,71:278-281.
  • 6BondenmullerH,BanauchD.Technicalevaluationofanewautomatedtumormarkerassay;theEnzymun testCYFRA211[].Tumorassociatedantigensoncogenesreceptorscytokinesintumordiagnosisandtherapyatthebeginningoftheth.1992
  • 7Stieber P,Hasholzner U,Bodenmuller H,et al.CYFRA21-1: a new marker in lung cancer[].Cancer.1993
  • 8Ebert W,Leichtweis B,Schapohler,et al.The new tumour marker CYFRA21-1 is superior to SCC antigen and CEA in the primary diagnosis of lung cancer[].TumorDiagnostik and Therapie.1993
  • 9Yamamoto K,Oka M,Hayashi H,et al.CYFRA21-1 is a useful marker for esophageal squamous cell carcinoma[].Cancer.1997
  • 10Pujol JL,Grenier J,Daures JP,et al.Serum fragment of cytokeratin subunit 19 measured by CYFRA21-1 immunoradiometric assay as a Marker of lung Cancer[].Cancer Research.1993

共引文献16

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部